Sporothrix Schenckii Infection Treatment Market: Osteoarticular sporotrichosis segment to dominate global market

Sporothrix Schenckii Infection Treatment Market: Introduction

Skin-related issues are one of the frequently occurring issues worldwide. One such issue is Sporotrichosis. Sporotrichosis is caused by a dimorphic fungus, called Sporothrix Schenckii, and is commonly called gardeners' disease due to number of people affected when carrying out cultivation in farms and gardensThe fungus is abundantly found in soil and on plant matter such as sphagnum moss and rose bushes, which makes it a valid reason for affecting people associated with gardening and cultivation. Fungal spores present in the environment are a major cause of Infection and usually affect cutaneous and subcutaneous tissues. Humans coming in contact with the spores that are present in the soil undergo this type of infection. Cutaneous (skin) infection is a commonly occurring form of this infection. It occurs when the fungus enters the skin through a small cut or scrape, especially when someone comes in contact with contaminated plant matter. Medicines employed majorly for the treatment of sporotrichosis include itraconazole and amphotericin B. Fluconazole and ketoconazole are used; however, they are utilized conditions when itraconazole therapy does not work.

Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81891

Key Drivers and Restraints of Global Sporothrix Schenckii Infection Treatment

  • Rise in number of Sporothrix Schenckii Infection cases and its prevalence worldwide is a key factor driving the market. Statistics and key trends from WHO indicate an increase in the number of people suffering from Sporothrix Schenckii infection, especially osteoarticular sporotrichosis and pulmonary sporotrichosis.
  • Less number of drugs available for the treatment of Sporothrix Schenckii infection along with their ineffectiveness in treatment of particular sporotrichosis such as disseminated sporotrichosis and technological advancements, such as continuous research and development activities being conducted for the development of a novel drug to enhance the quality of existing treatment options, are major factors that are projected to drive the Sporothrix Schenckii infection treatment market during the forecasted period
  • Lack of skilled professionals involved for the treatment and unavailability of healthcare infrastructure in several remote regions are projected to hamper the Sporothrix Schenckii infection treatment market during the forecast period

Osteoarticular sporotrichosis segment to dominate global Sporothrix Schenckii infection treatment market

  • Based on disease type, the global sporothrix schenckii infection treatment can be divided into Osteoarticular sporotrichosis, pulmonary sporotrichosis, disseminated sporotrichosis, children with sporotrichosis, and pregnant women with sporotrichosis.
  • The osteoarticular sporotrichosis segment dominated the global market in 2019. It is projected to maintain its dominant position during the forecast period due to marked increase in the number of patients particularly affected with this type of disease and its increased prevalence in the last few years.

Buy Sporothrix Schenckii Infection Treatment Report Market – https://www.transparencymarketresearch.com/checkout.php?rep_id=81891&ltype=S

Hospitals to be highly lucrative segment

  • Based on treatment type, the global Sporothrix Schenckii infection treatment market can be classified into drug treatment and surgery treatment. The drug treatment segment can be further split into itraconazole, amphotericin B, Saturated solution of potassium iodide (SSKI), and others.
  • The drugs treatment segment dominated the global Sporothrix Schenckii infection treatment Market due to increased effectiveness in treatment provided by different drugs. Drugs such as itraconazole and amphotericin B when administered to patients affected with Sporothrix Schenckii infection exhibited a higher recovery and survival rate and lesser side-effects than patients treated with surgery. These factors, cumulatively, propel the segment.

Hospitals to be highly lucrative segment

  • Based on end-user, global Sporothrix Schenckii infection treatment market can be divided into hospitals, specialty clinics, surgical centers, and others
  • The hospital segment dominated the global Sporothrix Schenckii infection treatment market due to marked percentage (%) increase in number of cases coming to hospitals and clinics day by day and increasing healthcare Infrastructure facilities provided by hospitals

 Request for Analysis of COVID19 Impact on Sporothrix Schenckii Infection Treatment Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81891

North America to dominate global Sporothrix Schenckii infection treatment market

  • In terms of region, the global Sporothrix Schenckii infection treatment market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Latin America, especially Brazil, accounted for a prominent share of the global Sporothrix Schenckii infection treatment market in 2019, followed by North America. Increase in number of affected cases and prevalence of Sporothrix Schenckii infection in Latin America with men involved in agricultural as well as other garden-related activities boosts the market in the region. Furthermore, in Brazil, the number of women over the age of 40 engaged in housework were highly affected, which also fueled the market in the region.

Key Manufacturers Operating in Market

The global Sporothrix Schenckii infection treatment was highly fragmented in 2019. Key manufacturers operating in the global market are:

  • Elanco.
  • Sentosa Geigy
  • Mylan Pharmaceuticals Inc
  • Accord-UK Ltd
  • Avimedical B.V
  • Success Pharmaceuticals

Global Sporothrix Schenckii Infection Treatment: Research Scope

Global Sporothrix Schenckii Infection Treatment, by Disease Type

  • Osteoarticular sporotrichosis
  • Pulmonary sporotrichosis
  • Disseminated sporotrichosis
  • Children with sporotrichosis  
  • Pregnant women with sporotrichosis

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
               

Back to news